Enhanced cardiomyocyte reactive oxygen species signaling promotes ibrutinib-induced atrial fibrillation

Atrial fibrillation (AF) occurs in up to 11% of cancer patients treated with ibrutinib. The pathophysiology of ibrutinib promoted AF is complicated, as there are multiple interactions involved; the detailed molecular mechanisms underlying this are still unclear. Here, we aimed to determine the elect...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Redox Biol
Glavni autori: Yang, Xinyu, An, Na, Zhong, Changming, Guan, Manke, Jiang, Yuchen, Li, Xinye, Zhang, Hanlai, Wang, Liqin, Ruan, Yanfei, Gao, Yonghong, Liu, Nian, Shang, Hongcai, Xing, Yanwei
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2020
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6994714/
https://ncbi.nlm.nih.gov/pubmed/31986467
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.redox.2020.101432
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items